Treatment Response and Eating Behavior Patterns in Patients Using Semaglutide

An Observational Study on the Therapeutic Effects of Semaglutide for Obesity : Relationship to Patients' Eating Behavior Patterns

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1041240034

Enrollment

Registered

2024-05-24

Start date

2024-05-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity obesity

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Among obese patients newly started on semaglutide, those who understood the purpose of the study and gave their consent

Exclusion criteria

Exclusion criteria: 1) Patients who have difficulty following the instructions of the principal investigator or sub-investigator 2) Other patients who are deemed inappropriate for this study by the principal investigator or sub-investigator.

Design outcomes

Primary

Measure	Time frame
Difference in BMI changes based on dietary preferences between the focus period and the reference period (The 24 weeks prior to drug administration are the reference (control) period, and the 24 weeks from the start of drug administration are the focus (exposure) period.)	—

Secondary

Measure	Time frame
Based on dietary preferences Differences in the changes in body weight, BMI, blood pressure, grip strength, respiratory quotient, body composition, bone density, blood biochemistry test results, and urine test (urine protein quantification) between the focus period and the reference period (The 24 weeks prior to drug administration are the reference (control) period, and the 24 weeks from the start of drug administration are the focus (exposure) period.) Changes in body weight and BMI from baseline to 0, 24, and 52 weeks after administration Changes in body weight, BMI, blood pressure, grip strength, respiratory quotient, body composition, bone density, dietary content (total energy intake, various nutrients, intake of each food item), blood biochemistry test results, and urine test (urine protein quantification) from baseline to 12, 24, and 52 weeks after administration Changes in dietary preferences at 12, 24, and 52 weeks after drug administration Based on dietary content Differences in the changes in body weight, BMI, blood pressure, grip strength, respiratory quotient, body composition, bone density, blood biochemistry test results, and urine test (urine protein quantification) between the focus period and the reference period (The 24 weeks prior to drug administration are the reference (control) period, and the 24 weeks from the start of drug administration are the focus (exposure) period.) Changes in body weight, BMI, blood pressure, grip strength, respiratory quotient, body composition, bone density, dietary content (total energy intake, various nutrients, intake of each food item), and blood biochemistry test results from baseline to 12, 24, and 52 weeks after administration Medication adherence rate and medication details during the drug administration period	—

Measure

Time frame

Based on dietary preferences Differences in the changes in body weight, BMI, blood pressure, grip strength, respiratory quotient, body composition, bone density, blood biochemistry test results, and urine test (urine protein quantification) between the focus period and the reference period (The 24 weeks prior to drug administration are the reference (control) period, and the 24 weeks from the start of drug administration are the focus (exposure) period.) Changes in body weight and BMI from baseline to 0, 24, and 52 weeks after administration Changes in body weight, BMI, blood pressure, grip strength, respiratory quotient, body composition, bone density, dietary content (total energy intake, various nutrients, intake of each food item), blood biochemistry test results, and urine test (urine protein quantification) from baseline to 12, 24, and 52 weeks after administration Changes in dietary preferences at 12, 24, and 52 weeks after drug administration Based on dietary content Differences in the changes in body weight, BMI, blood pressure, grip strength, respiratory quotient, body composition, bone density, blood biochemistry test results, and urine test (urine protein quantification) between the focus period and the reference period (The 24 weeks prior to drug administration are the reference (control) period, and the 24 weeks from the start of drug administration are the focus (exposure) period.) Changes in body weight, BMI, blood pressure, grip strength, respiratory quotient, body composition, bone density, dietary content (total energy intake, various nutrients, intake of each food item), and blood biochemistry test results from baseline to 12, 24, and 52 weeks after administration Medication adherence rate and medication details during the drug administration period

—

Contacts

Public ContactSeiya Banno

Gifu University Graduate School of Medicine

sei6105@gmail.com+81-582306377

Outcome results